Affluent Medical SAS (AFME) — Tangible Net Worth Ratio
Affluent Medical SAS (AFME) has a Tangible Net Worth Ratio of 32.7% as of June 2025. This metric is calculated by deducting intangible assets (€14.21 Million) from net assets (€21.11 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See shareholders equity of Affluent Medical SAS for net asset value and shareholders' equity analysis.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Affluent Medical SAS Tangible Net Worth Ratio (2016–2024)
This chart shows how Affluent Medical SAS's Tangible Net Worth Ratio has changed across 8 annual periods from 2016 to 2024. As of June 2025, the ratio stands at 32.7%, reflecting net assets of €21.11 Million with intangible assets of €14.21 Million EUR. Also explore Affluent Medical SAS annual equity growth to track the company's year-over-year net asset growth rate.
Annual Tangible Net Worth Ratio for Affluent Medical SAS (2016–2024)
The table below presents the year-by-year Tangible Net Worth Ratio for Affluent Medical SAS from 2016 to 2024, covering 8 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see AFME market cap overview.
| Year | Tangible NW Ratio | Net Assets (EUR) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 50.0% | €30.27 Million | €15.14 Million | €60.86 Million | ▲ +4.0 pp |
| 2023 | 46.0% | €31.47 Million | €16.99 Million | €56.62 Million | ▲ +1.7 pp |
| 2022 | 44.4% | €33.83 Million | €18.82 Million | €60.02 Million | ▼ -8.1 pp |
| 2021 | 52.5% | €43.53 Million | €20.70 Million | €70.03 Million | ▲ +16.4 pp |
| 2020 | 36.1% | €35.29 Million | €22.57 Million | €64.83 Million | ▲ +119.0 pp |
| 2019 | -82.9% | €30.96 Million | €56.65 Million | €65.25 Million | ▼ -180.0 pp |
| 2017 | 97.0% | €61.39 Million | €1.82 Million | €67.39 Million | ▲ +0.5 pp |
| 2016 | 96.6% | €58.87 Million | €2.02 Million | €61.72 Million | — |